From: Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up
Cohort | Setting | Indication | Positive predictive value (%) | Negative predictive value at 24-months (%) |
---|---|---|---|---|
Stage 1 | Baseline | Total: Routine or clinical suspicion# | NA | 95.7 |
Active surveillance | Total: Routine, clinical suspicion or unknown | 100 | 91.1 | |
Routine | 100 | 93.6 | ||
Clinical suspicion# | 100 | 85.7 | ||
Advanced | Baseline | Total: Routine or clinical suspicion# | 100 | 0 |
Follow-up | Total: Routine, clinical suspicion#or post-treatment | 77.1 | 90.9 | |
Routine | 42.9 | 100 | ||
Clinical suspicion# | 100 | 93.8 | ||
Post-treatment* | 60 | 89.1 |